ESR1 and breast carcinoma: Although amplification of a region of chromosome 11 (q13) is a common finding in breast cancer and the most consistently overexpressed oncogene from this region is Cyclin D1, there is evidence that Cyclin D1 overexpression is a favourable prognostic sign, associated with ER-positive, well-differentiated tumours (Barnes and Gillett, 1998).